TGFB1 and coronary artery disorder: In conclusion, the present study demonstrated that TGF-β1 promoted cardiomyogenicdifferentiation of rBMSCs, and that the implantation of these cells can improve thefunction of the injured myocardial tissue, which may represent a potential therapeuticstrategy for the treatment of ischemic heart disease.